Anvisa changes shelf life and commercial presentations of CBD-based products. See what changes for Herbarium and Fiocruz on Portal Sechat.

Following improvement in Parkinson's symptoms, state representative advocates for democratizing treatment and expanding access to cannabis-based medications through the public healthcare system.

AbraRio becomes the second Brazilian association with a final ruling for medical cannabis cultivation and the first in Rio de Janeiro. Read the interview:

Understand the Anvisa Resolution published in the Diário Oficial pointing out advertisements for cannabis-derived products without agency registration or authorization.

Published in the Federal Official Gazette, RDC No. 1,039/2026 establishes good practice criteria, ISO 17025 accreditation, and accreditation rules within Reblas, directly impacting the quality control of medical cannabis and industrial hemp products.

Data presented by Rafael Cairê de Oliveira dos Santos during a public hearing of the Parliamentary Front for Medicinal Cannabis and Industrial Hemp at Alesp show the evolution of public care and the territorial expansion of treatments in the State of São Paulo.

Anvisa directors meet this Wednesday (28) to discuss the update of medicinal cannabis regulations; learn how to follow

Study will analyze if the distinction of 40 grams for users reduced incarceration and socio-racial inequality, evaluating the practical effects of the new drug policy